Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,694 | -4,456 | -6,560 | -4,276 | -21,102 |
| Depreciation Amortization | 41 | 31 | 20 | 10 | 30 |
| Accounts payable and accrued liabilities | -165 | 38 | -315 | 64 | -1,034 |
| Other Working Capital | -669 | -506 | -593 | -622 | -478 |
| Other Operating Activity | 2,144 | 1,674 | 1,147 | 339 | 3,249 |
| Operating Cash Flow | $-4,343 | $-3,219 | $-6,301 | $-4,485 | $-19,335 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -47 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-47 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,569 | 6,569 | 6,569 | 6,569 | 1,233 |
| Other Financing Activity | -38 | -10 | 0 | 0 | -55 |
| Financing Cash Flow | $6,531 | $6,559 | $6,569 | $6,569 | $1,178 |
| Beginning Cash Position | 8,680 | 8,680 | 8,680 | 8,680 | 26,884 |
| End Cash Position | 10,868 | 12,020 | 8,948 | 10,764 | 8,680 |
| Net Cash Flow | $2,188 | $3,340 | $268 | $2,084 | $-18,204 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,343 | -3,219 | -6,301 | -4,485 | -19,335 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -47 |
| Free Cash Flow | -4,343 | -3,219 | -6,301 | -4,485 | -19,382 |